|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/39 | (2006.01) |
| A61K 31/4745 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/713 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 35/15 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 39/39 | (2013.01) | ||
| A61K 31/713 | (2006.01) | ||
| A61K 35/15 | (2015.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61P 7/00 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/519 | (2006.01) | ||
| C07K 16/18 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/76 | (2013.01) |
| (11) | Patento numeris | 3656443 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19197485.6 |
| Europos patento paraiškos padavimo data | 2016-01-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-05-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201562106050 P | 2015-01-21 | US |
| (72) |
WEISSMAN, Irving L. , US
FENG, Mingye , US
VOLKMER, Jens-Peter , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS |
| USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS |